¿Cuáles son los estados financieros clave de Ludwig Enterprises Inc?
¿Cuáles son los ratios financieros clave para LUDG?
¿Cómo se desglosan los ingresos de Ludwig Enterprises Inc por segmento o geografía?
¿Es rentable Ludwig Enterprises Inc?
¿Tiene Ludwig Enterprises Inc alguna deuda?
¿Cuántas acciones en circulación tiene Ludwig Enterprises Inc?
Estadísticas clave
Cierre Anterior
$0.0205
Precio de apertura
$0.0221
Rango del día
$0.0221 - $0.0221
Rango de 52 semanas
$0.021 - $0.155
Volumen
1
Volumen promedio
10.3K
EPS (TTM)
--
Rendimiento de dividendos
--
Cap. de mercado
$6.9M
¿Qué es LUDG?
Ludwig Enterprises Inc, operates as a biotech and healthcare holding company. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2007-12-11. Its proprietary mRNA genomic technology has the potential of screening for genetic biomarkers for inflammatory-driven diseases, including, but not limited to, heart disease, diabetes, preeclampsia, cancer and long COVID. The firm employs a non-invasive cheek swab test to collect mRNA samples. Its initial product candidate is the Revealia Breast test, a non-invasive cheek swab assay designed to detect molecular signatures in mRNA expression associated with the presence of breast cancer. Its technology platform integrates three key components: non-invasive sample collection, genomic analysis, and machine learning-based interpretation.